SLC15A1 and colitis: This study reveals that the oral administration of Gln and Ala-Gln can protect against DSS-induced colitis through alleviating mucosa damage and inflammatory responses, upregulating the expression of TJ and PepT1 proteins and modulating gut microbiota in mice.